Given that post-translation modifications of AMPK-β1 (i.e., myristoylation and phosphorylation) are essential for AMPK activity [27], the expression status of AMPK-β1 may determine the AMPK activity in ovarian cancer progression. The gene discussed is PRKAA2; the disease is ovarian cancer.